Lonsha provides a wide range of services and products to the pharmaceutical, consumer health and nutrition industries, from early discovery to customized development and production of active pharmaceutical ingredients to innovative dosage forms. Longsha ’s scale and resources show that Longsha has the strength to provide customers with one-stop solutions to help people recover, keep their body and mind happy and enjoy a better life. In 2021, Longsha will support more than 780 preclinical and clinical small molecule/macromolecular drugs, as well as 245 commercial stages of small molecule/macromolecular drugs, and produce up to 250 billion capsules.

In 1897, Ronsha was born in the Alps in Switzerland. To date, its business has spread to five continents around the world. With approximately 16,000 full-time employees, the efficient team and each of them have made significant changes to Longsha ’s business and region and country. Longsha ’s business benefits from global supply chains, but Longsha has been working hard to maintain flexibility to meet local market demand.

Being a responsible company and committed to sustainable development is Longsha's firm commitment and the basis for Longsha to do all its work well. Reducing environmental impact, saving energy and natural resources, and continuously improving people's quality of life are the core of corporate culture. Longsha’s “Zero Accident Vision” plan is a good proof that Longsha strives to achieve gig work-related accidents, zero environmental accidents, zero product transportation accidents and zero production process accidents. Longsha makes every effort to attract and retain outstanding talents and actively achieve significant changes for Longsha 's company and the region.

In 2021, the company's sales reached CHF 5.4 billion, and its core business earnings before interest, tax, depreciation and amortization (EBITDA) reached CHF 1.7 billion. Longsha shares are listed on the Swiss Stock Exchange and the Swiss Market Index (SMI), respectively, and are also listed on the Singapore Exchange for secondary listing.